Final Report - REPROBESITY (Search for new therapeutic agents against complicated obesity by reprofiling existing drugs)
Project ID: 223713Funded under: FP7-HEALTH
This is the final report of REPROBESITY project, funded under the European Commission (EC)'s Seventh Framework Programme (FP7). REPROBESITY aimed at finding new indications of existing drugs with proven safety profiles as anti-obesity therapies and phenotypes and biomarkers that identify subsets of patients with safe and efficacious responses to drugs. The report discusses the epidemics of obesity and presents the project scope under seven objectives. It presents in detail the results accomplished with and presents the dissemination that has taken place.
Download application/zip (3135544)
Record Number: 14257 / Last updated on: 2013-02-01